Skip to content
★ Sign in to follow
SE

Sven Eriksson

Isofol Medical AB
Total declarations
7
Company
1
▲ Purchases (3 ops.)
€35k
▼ Sales (2 ops.)
€7,151

Latest filing published 17 Nov 2020 for Isofol Medical AB, €4,234.

Filing timeline

BuySale
Sven Eriksson

Insider track record

Disclosed buys
3
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Sven Eriksson: trading record in brief

This profile gathers the share dealings of Sven Eriksson in Isofol Medical AB. Between 16 May 2018 and 16 November 2020, the trades on record add up to 7 filings.

In open-market terms, that means 3 purchases worth €35k on one side and 2 sales worth €7,151 on the other. Purchases outweigh sales by €28k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings no purchases and 2 sales.

A typical purchase (the median) is worth €12k.

The latest filing, published on 17 November 2020, reports an open-market sale of €4,234 in Isofol Medical AB. The latest purchase dates back some time: it was published 2,781 days ago, on 29 March 2019. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Sven Eriksson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▼
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIsofol Medical AB
    43,488 SEK0FI-SE
    58,767 shares@ SEK 0.748.7% of flowTeckningsoptionISIN SE0009581051FI:csv-56a82e73769d6e997b20
  • ▼
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIsofol Medical AB
    29,971 SEK0FI-SE
    58,767 shares@ SEK 0.516.0% of flowTeckningsoptionISIN SE0009581051FI:csv-dd7020c29fd6450a86c1
  • ●
    Chief Commercial OfficerExecutivesIsofol Medical AB
    32,662 SEK0FI-SE
    9,332 shares@ SEK 3.507.5% of flowBTA (betald tecknad aktie)ISIN SE0009581051FI:csv-6bc316ed0f8291a62071
  • ●
    Chief Commercial OfficerExecutivesIsofol Medical AB
    32,281 SEK0FI-SE
    9,223 shares@ SEK 3.507.4% of flowBTA (betald tecknad aktie)ISIN SE0009581051FI:csv-dab8ff9ffdf744070d7f
  • ▲
    Chief Commercial OfficerExecutivesIsofol Medical AB
    129,581 SEK0FI-SE
    88,150 shares@ SEK 1.4725.4% of flowTeckningsoptionISIN SE0009581051FI:csv-68607fa2734d32a031d6
    Canonical exit: 24 Jun 2019 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesIsofol Medical AB
    77,572 SEK0FI-SE
    88,150 shares@ SEK 0.8815.2% of flowTeckningsoptionISIN SE0009581051FI:csv-2b1eef41df8b1171eecf
    Canonical exit: 24 Jun 2019 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesIsofol Medical AB
    161,000 SEK14FI-SE
    7,000 shares@ SEK 23.0032.1% of flowISIN SE0009581051FI:csv-dcbc4b680d420fae4cd1
    Canonical exit: 14 Aug 2018 (T+90)

7 of 7 declarations